SAN FRANCISCO -- More adults with moderate-to-severe Crohn's disease (CD) reached clinical remission after 6 months on ...

Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...

An ustekinumab biosimilar to Stelara launched in France, completing its rollout across 5 major European markets and paving ...

identical to the original drug Stelara developed by Johnson & Johnson. The SC formulation is available in doses of 45 mg and 90 mg, while the IV formulation is available in a 130 mg dose ...

Although MG hasn’t revealed exact specifications yet, going by the dimensions of the international-spec D90 Max, the Majestor could measure 5,046mm in length, 2,016mm in width and 1,876mm in ...

Several headwinds are impacting the company, including generic competition for its blockbuster drug Stelara, the ongoing talc lawsuit (which could see a final decision in the first half of the ...

Overall, global Stelara sales dropped 14.7% year-over-year to roughly $2.3 billion in 2024’s fourth quarter. For the full 12-month earnings period, Stelara sales slipped around 4.6% to $10.4 ...

Investors are watching biosimilar competition with immunology drug Stelara, which extended to the key US market in January. We assume a more than $3 billion decline in global Stelara sales in 2025.

Using a single PBM as the sole distribution channel is unprecedented. Without a lot of fanfare or a news release, Wezlana (ustekinumab-auub), the first Stelara (ustekinumab) biosimilar has hit the ...

Rugby league personality Mark ‘MG’ Geyer is joining Sydney’s 2GB and Nine Radio on a three-year deal. The NSW and Australian representative and NRL premiership winner will be heard daily on 2GB’s new ...

NRL legend Mark ‘MG’ Geyer, who was let go from Triple M after 17 years on air, has landed a new high profile radio gig. Geyer has signed a three year deal with 2GB radio in Sydney ...

Noteably, Pyzchiva joins Wezlana (ustekinumab-auub) in the interchangeability club, making them the only 2 ustekinumab biosimilars able to be switched in for the reference product at the pharmacy ...